Yüklüyor......

COT-02 The opening of tumor treating fields with online support system

Background: EF-14 trial showed the efficacy of tumor treating fields (TTF), and TTF was approved as a standard therapy for glioblastoma. In TTF opening, Device Support Specialist (DSS) should explain how to use it for the patient and family. However no DSS does always stay in our Yamaguchi prefectur...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neurooncol Adv
Asıl Yazarlar: Sadahiro, Hirokazu, Sugimoto, Kazutaka, Nomura, Sadahiro
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2020
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7699128/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdaa143.092
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!